Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01247324 |
|---|---|
| Brief Title: | A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis |
| First Submitted : | November 23, 2010 |
| First Submitted that Met QC Criteria : | November 23, 2010 |
| First Posted : | November 24, 2010 (Estimate) |
| Results First Submitted : | March 30, 2017 |
| Results First Submitted that Met QC Criteria : | July 17, 2017 |
| Results First Posted : | July 18, 2017 |
| Certification/Extension First Submitted : | October 10, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | October 10, 2016 |
| Certification/Extension First Posted : | October 12, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 13, 2024 |
| Last Update Posted : | March 4, 2024 |